PE31095A1 - Derivados cristalinos del acido n-acetil neuraminico y procesos para su preparacion - Google Patents

Derivados cristalinos del acido n-acetil neuraminico y procesos para su preparacion

Info

Publication number
PE31095A1
PE31095A1 PE1994257245A PE25724594A PE31095A1 PE 31095 A1 PE31095 A1 PE 31095A1 PE 1994257245 A PE1994257245 A PE 1994257245A PE 25724594 A PE25724594 A PE 25724594A PE 31095 A1 PE31095 A1 PE 31095A1
Authority
PE
Peru
Prior art keywords
preparation
processes
guanidino
neuraminic acid
acetyl neuraminic
Prior art date
Application number
PE1994257245A
Other languages
English (en)
Inventor
Christopher Williamson
William James White
Vipulkumar Patel
Original Assignee
Biota Scient Management
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biota Scient Management filed Critical Biota Scient Management
Publication of PE31095A1 publication Critical patent/PE31095A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE REFIERE A FORMAS CRISTALINAS DEL ACIDO 5-ACETAMIDO-2,3,4,5-TETRADESOXI-4-GUANIDINO-D-GLICERO-D-GALACTO-NON-2-ENOPIRANOSONICO (ANALOGO 4-GUANIDINO DE DANA), UTIL COMO FARMACO ANTIVIRAL, DE FORMULA GENERAL I, TALES COMO: 1) UN MONOHIDRATO TABULAR QUE PUEDE CAPTAR AGUA DEPENDIENDO DE LA HUMEDAD RELATIVA DEL MEDIO AMBIENTE, AL PERDER ENTRE 80ºC A 90ºC SU AGUA DE CRISTALIZACION, ES ADECUADO PARA LA MICRONIZACION Y SE OBTIENE A PARTIR DE UNA SOLUCION ACUOSA RELATIVAMENTE CONCENTRADA A UNA TEMPERATURA ENTRE 50º A 55ºC QUE ES SEMBRADA CON CRISTALES; 2) UN DIHIDRATO EN AGUJAS, ESTABLE A LA HUMEDAD, QUE PIERDE SU AGUA DE CRISTALIZACION ENTRE 84º A 90ºC Y 135ºC A 143ºC, ES ADECUADO PARA LA PREPARACION DE SOLUCIONES Y SUSPENSIONES ACUOSAS Y SE OBTIENE A PARTIR DE UNA SOLUCION ACUOSA RELATIVAMENTE DILUIDA A UNA TEMPERATURA ENTRE 20ºC A 30ºC A LA QUE SE ADICIONA UN CONTRASOLVENTE COMO ACETONA
PE1994257245A 1993-12-17 1994-12-15 Derivados cristalinos del acido n-acetil neuraminico y procesos para su preparacion PE31095A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939325841A GB9325841D0 (en) 1993-12-17 1993-12-17 Chemical compounds

Publications (1)

Publication Number Publication Date
PE31095A1 true PE31095A1 (es) 1995-10-18

Family

ID=10746778

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1994257245A PE31095A1 (es) 1993-12-17 1994-12-15 Derivados cristalinos del acido n-acetil neuraminico y procesos para su preparacion

Country Status (44)

Country Link
US (2) US6294572B1 (es)
EP (1) EP0734382B1 (es)
JP (1) JP3317972B2 (es)
KR (1) KR100403256B1 (es)
CN (2) CN1502621A (es)
AP (2) AP9600810A0 (es)
AT (1) ATE199255T1 (es)
BG (1) BG63338B1 (es)
BR (2) BR9408340A (es)
CA (1) CA2177990C (es)
CO (1) CO4340619A1 (es)
CZ (1) CZ289234B6 (es)
DE (1) DE69426726T2 (es)
DK (1) DK0734382T3 (es)
EE (1) EE03353B1 (es)
EG (1) EG20597A (es)
ES (1) ES2155517T3 (es)
FI (1) FI120453B (es)
GB (1) GB9325841D0 (es)
GR (1) GR3035681T3 (es)
HK (1) HK1014187A1 (es)
HR (1) HRP941001B1 (es)
HU (1) HU221971B1 (es)
IL (1) IL112011A (es)
IS (1) IS4240A (es)
MA (1) MA23396A1 (es)
MY (1) MY116221A (es)
NO (1) NO314759B1 (es)
NZ (1) NZ277789A (es)
OA (2) OA10325A (es)
PE (1) PE31095A1 (es)
PL (1) PL186384B1 (es)
PT (1) PT734382E (es)
RO (1) RO114792B1 (es)
RU (1) RU2134690C1 (es)
SA (1) SA94150417B1 (es)
SG (1) SG46669A1 (es)
SI (1) SI0734382T1 (es)
SK (1) SK282972B6 (es)
SV (1) SV1994000076A (es)
TW (1) TW452577B (es)
UA (1) UA46723C2 (es)
WO (1) WO1995016680A1 (es)
ZA (1) ZA9410003B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325841D0 (en) * 1993-12-17 1994-02-23 Glaxo Group Ltd Chemical compounds
US5866601A (en) * 1995-02-27 1999-02-02 Gilead Sciences, Inc. Carbocyclic compounds
HU228450B1 (en) 1995-02-27 2013-03-28 Gilead Sciences Inc Novel selective inhibitors of viral or bacterial neuraminidases
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
EP0823428B1 (en) * 1996-07-22 2002-01-02 Sankyo Company Limited Neuraminic acid derivatives, their preparation and their medical use
US6340702B1 (en) 1996-07-22 2002-01-22 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
US6451766B1 (en) 1996-07-22 2002-09-17 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
US5859284A (en) * 1996-08-23 1999-01-12 Gilead Sciences, Inc. Preparation of carbocyclic compounds
US6518438B2 (en) 1996-08-23 2003-02-11 Gilead Sciences, Inc. Preparation of cyclohexene carboxylate derivatives
US5994377A (en) * 1996-10-21 1999-11-30 Gilead Sciences, Inc. Piperidine compounds
US5886213A (en) * 1997-08-22 1999-03-23 Gilead Sciences, Inc. Preparation of carbocyclic compounds
TW477783B (en) * 1997-12-12 2002-03-01 Gilead Sciences Inc Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same
TWI291462B (en) 2000-04-25 2007-12-21 Daiichi Sankyo Co Ltd Hydrate crystal of neuraminic acid compound
US20080063722A1 (en) * 2006-09-08 2008-03-13 Advanced Inhalation Research, Inc. Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
EP2792676A4 (en) * 2011-12-16 2015-10-07 Daiichi Sankyo Co Ltd PROCESS FOR PREPARING NEURAMINE ACID DERIVATIVES
CN109232677B (zh) * 2018-10-18 2021-12-28 中国科学院合肥物质科学研究院 一种使n-乙酰神经氨酸水合物转化为n-乙酰神经氨酸的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP249A (en) * 1990-04-24 1993-03-17 Biota Scient Management Pty Ltd Anti-viral compounds.
AU659501B2 (en) * 1991-10-23 1995-05-18 Biota Scientific Management Pty Ltd Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid
US5639786A (en) 1992-12-04 1997-06-17 Biota Scientific Management, Pty., Ltd. Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of α-D-neuraninic acid
GB9325841D0 (en) * 1993-12-17 1994-02-23 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
PL315055A1 (en) 1996-09-30
CN1142820A (zh) 1997-02-12
RU2134690C1 (ru) 1999-08-20
WO1995016680A1 (en) 1995-06-22
AP541A (en) 1996-10-01
NO314759B1 (no) 2003-05-19
SK282972B6 (sk) 2003-01-09
BG63338B1 (bg) 2001-10-31
GB9325841D0 (en) 1994-02-23
CZ169396A3 (en) 1996-11-13
UA46723C2 (uk) 2002-06-17
CN1132829C (zh) 2003-12-31
BG100709A (bg) 1997-01-31
EP0734382B1 (en) 2001-02-21
NZ277789A (en) 1999-04-29
JP3317972B2 (ja) 2002-08-26
CZ289234B6 (cs) 2001-12-12
HU9601642D0 (en) 1996-08-28
DE69426726T2 (de) 2001-06-21
KR100403256B1 (ko) 2004-04-30
SA94150417B1 (ar) 2005-12-18
EE03353B1 (et) 2001-02-15
ES2155517T3 (es) 2001-05-16
NO962545D0 (no) 1996-06-14
OA10325A (en) 1997-10-07
FI962464A (fi) 1996-06-13
US6294572B1 (en) 2001-09-25
NO962545L (no) 1996-06-14
DE69426726D1 (de) 2001-03-29
SI0734382T1 (en) 2001-08-31
FI120453B (fi) 2009-10-30
CA2177990C (en) 2000-04-25
IL112011A0 (en) 1995-03-15
AU689185B2 (en) 1998-03-26
HU221971B1 (hu) 2003-03-28
EG20597A (en) 1999-09-30
IS4240A (is) 1995-06-18
SG46669A1 (en) 1998-02-20
CA2177990A1 (en) 1995-06-22
US20020037865A1 (en) 2002-03-28
TW452577B (en) 2001-09-01
CO4340619A1 (es) 1996-07-30
EP0734382A1 (en) 1996-10-02
BR9408340A (pt) 1997-08-19
AP9600810A0 (en) 1996-07-31
MA23396A1 (fr) 1995-07-01
DK0734382T3 (da) 2001-03-19
HRP941001B1 (en) 2001-06-30
HK1014187A1 (en) 1999-09-24
IL112011A (en) 1998-08-16
PT734382E (pt) 2001-06-29
OA11275A (en) 2002-11-20
ZA9410003B (en) 1995-07-25
PL186384B1 (pl) 2004-01-30
CN1502621A (zh) 2004-06-09
FI962464A0 (fi) 1996-06-13
GR3035681T3 (en) 2001-06-29
RO114792B1 (ro) 1999-07-30
HUT74938A (en) 1997-03-28
HRP941001A2 (en) 1997-06-30
BR1100548KB1 (pt) 2011-11-01
AU1314495A (en) 1995-07-03
ATE199255T1 (de) 2001-03-15
MY116221A (en) 2003-12-31
JPH09506601A (ja) 1997-06-30
SV1994000076A (es) 1995-10-26
AP9400705A0 (en) 1995-01-31
SK78596A3 (en) 1997-03-05

Similar Documents

Publication Publication Date Title
PE31095A1 (es) Derivados cristalinos del acido n-acetil neuraminico y procesos para su preparacion
FR2301479A1 (fr) Procede de preparation de ferrierite
Chisholm et al. Biosynthesis of mustard oil glucosides: IV. The administration of methionine-C14 and related compounds to horseradish
ES2126355T3 (es) Procedimiento para la preparacion de creatina o monohidrato de creatina.
ES2069278T3 (es) Proceso para la produccion de disoluciones concentradas de gran pureza de hipoclorito potasico.
GB1486156A (en) Increasing sucrose content
ES468165A1 (es) Procedimiento para la obtencion de cristales de carbonato desodio monohidratado
GB1232554A (es)
CU23171A3 (es) Procedimiento para la preparacion de sal de calcio de zofenopril
BR8704268A (pt) Processo para a flegmatizacao de acidos peroxicarboxilicos insoluveis na agua
GB945578A (en) Mono adducts of dialdehydes
JPS6428207A (en) Sodium sulfide anhydrous single crystal and production thereof
KR930009984A (ko) 5'-구아닐산 나트륨의 정석법
JPS6019285B2 (ja) 分別方法
US2509084A (en) Methylation of xanthine to form caffeine
GB1082915A (en) Alkali metal-d,1-malate monohydrates and their preparation
BR0307879A (pt) Método para purificar um composto de nióbio e/ou um composto de tântalo altamente puro
GB773661A (en) Improvements in or relating to process for resolving dl-glutamic acid
SU763333A1 (ru) Способ стабилизации сол нокислого цистеина
GB127716A (en) Improvements in and relating to the Manufacture of Sulphate of Ammonia.
SU366709A1 (ru) Способ получени тетра- -алкильных производных бициклических мочевин
KR900017905A (ko) 낮은 황산 암모늄 함량을 갖는 결정성 황산 히드록실암모늄의 제조방법
GB1529448A (en) 6-amidinopenicillanic acid derivatives
GB824442A (en) Improvements in or relating to the manufacture of pentaerythritol or derivatives thereof
JPS55127360A (en) Preparation of cystamine sulfate

Legal Events

Date Code Title Description
FC Refusal